| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. (KRYS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 79 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $522.01M | - | |
| Pres | 1.43M | $496.94M | - | |
| Dir | 75.7K | $26.34M | - | |
| Dir | 5.0K | $1.74M | - | |
| Dir | 5.0K | $1.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $170.95 | $8,547,718.98 | -0.2% | +3.8% | +8.5% | |
| Feb 28, 2024 | Romano Kathryn | Chief Accounting Officer | Sale+OE | 5,000 | $165.88 | $829,416.89 | -4.6% | -2.5% | +6.3% | |
| Feb 28, 2024 | Romano Kathryn | Chief Accounting Officer | Sale+OE | 7,500 | $166.05 | $1,245,380.71 | -3.7% | -2.5% | +6.3% | |
| Feb 26, 2024 | Romano Kathryn | Chief Accounting Officer | Sale+OE | 8,087 | $136.91 | $1,107,180.00 | -24.4% | +1.3% | +15.4% | |
| Jan 22, 2024 | Romano Kathryn | Chief Accounting Officer | Sale+OE | 2,500 | $130.00 | $325,000.00 | -16.6% | +20.0% | +15.7% | |
| Dec 11, 2023 | Krishnan Suma46 | President, R&D | Sell | 50,000 | $105.67 | $5,283,290.75 | -0.4% | +60.7% | +75.2% | |
| Dec 11, 2023 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $105.67 | $5,283,290.75 | -0.4% | +60.7% | +75.2% | |
| Sep 11, 2023 | Krishnan Suma46 | President, R&D | Sell | 50,000 | $127.23 | $6,361,680.43 | -0.3% | -17.5% | +44.0% | |
| Sep 11, 2023 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $127.23 | $6,361,680.43 | -0.3% | -17.5% | +44.0% | |
| Jun 9, 2023 | Orth Andrew C. | Chief Commercial Officer | Sale+OE | 12,500 | $128.61 | $1,607,634.90 | -61.4% | -6.0% | +27.5% |